Molecular characterization of congenital mesoblastic nephroma and its distinction from wilms Tumor

Gail E. Tornlinson, J. Craig Argyle, Susana Velasco, Perry D. Nisen

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Background. Congenital mesoblastic nephroma (CMN) is a rare tumor of the neonatal kidney. It was once thought to be a variant of Wilms tumor that also arises from primitive renal cells. Methods. Molecular characteristics of two CMN were studied to clarify their potential relationship to Wilms tumors. Patterns of gene expression were assayed by Northern blot hybridization analysis. Tumors were tested for loss of heterozygosity (LOH) at chromosomes 11:13 and 11:15 using Southern blot analysis. Results. The CMN, like Wilms tumors, demonstrated high‐level expression of insulin‐like growth factor 11. Unlike Wilms tumors, however, the CMN expressed neither the N‐myc oncogene nor the putative Wilms tumor suppressor gene, WT1. Using a panel of probes spanning 11:13 and 11:15, no LOH was detected in the CMN, nor was there evidence of deletion or rearrangements of WT1. Conclusions. Although Wilms tumor and CMN both arise from the developing kidney, molecular characterization suggests that different factors are involved in the pathogenesis of these two tumors. Cancer 1992; 70:2358‐2361.

Original languageEnglish (US)
Pages (from-to)2358-2361
Number of pages4
Issue number9
StatePublished - Nov 1 1992
Externally publishedYes


  • Wilms tumor
  • congenital mesoblastic nephroma
  • gene expression

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Molecular characterization of congenital mesoblastic nephroma and its distinction from wilms Tumor'. Together they form a unique fingerprint.

Cite this